Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

An Alternative Pathway Specific Flow Cytometric Assay to Detect Complement Activation in Atypical Hemolytic Uremic Syndrome (aHUS)

Jia Yu, Xuan Yuan, MD MSc, Kang Zhou, Daniel White, Samuel A. Merrill, MD PhD, Robert A. Brodsky, MD

Blood (2018) 132 (Supplement 1): 3748.

https://doi.org/10.1182/blood-2018-99-119445

Published: 2018

Journal Articles

Chronic Kidney Disease, Hypertension and Cardiovascular Sequelae during Long Term Follow up of Adults with Atypical Hemolytic Uremic Syndrome

Shruti Chaturvedi, MBBS, MS, Alison R. Moliterno, MD, Samuel A. Merrill, MD PhD, Evan M Braunstein, MD PhD, Xuan Yuan, MD MSc, Christopher John Sperati, MD, Gebran Khneizer, Robert A. Brodsky, MD

Blood (2018) 132 (Supplement 1): 3754.

https://doi.org/10.1182/blood-2018-99-119999

Published: 2018

Journal Articles

Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Center Study

Fares Alsawah, MD BS, MS, Samuel A. Merrill, MD PhD, Paula L. Bockenstedt, MD, Erica L. Campagnaro, MD, Sumana Devata, MD, Scott D. Gitlin, MD, Mark S Kaminski, MD, Alice M. Cusick, MD, Tycel J. Phillips, MD, Suman L. Sood, MD, Moshe Talpaz, MD, Albert Thomas Quiery, MD, Philip S Boonstra, PhD, Asra Z. Ahmed, MD, Ryan A. Wilcox, MD PhD

Blood (2018) 132 (Supplement 1): 1119.

https://doi.org/10.1182/blood-2018-99-116854

Published: 2018

Journal Articles

Adult Hemophagocytic Lymphohistiocytosis-a Quality Improvement Initiative

Samuel A. Merrill, MD PhD, Rakhi P. Naik, MD, Evan M Braunstein, MDPhD, Michael B. Streiff, Satish Shanbhag, MD, Sophie Lanzkron, MD, Alison R. Moliterno, MD, Robert A. Brodsky, MD

Blood (2017) 130 (Supplement 1): 677.

https://doi.org/10.1182/blood.V130.Suppl_1.677.221

Published: 2017

Journal Articles

Eculizumab cessation in atypical hemolytic uremic syndrome

Samuel A. Merrill, Zachary D. Brittingham, Xuan Yuan, Alison R. Moliterno, C. John Sperati, Robert A. Brodsky

Blood (2017) 130 (3): 368–372.

https://doi.org/10.1182/blood-2017-02-770214

Published: 2017

Includes: Supplemental data

Journal Articles

Relative and Absolute Platelet Count Drops As a Risk Factor for Mortality, Bleeding, and Venous Thrombosis in Hospitalized Medical Patients

Matthew E. Lebow, BA, NREMT-P, Michael DeSarno, MS, Damon Eugene Houghton, MDBS, John P. Winters, III, MD, Samuel A. Merrill, MDPhD, George F. Atweh, MD, Neil A Zakai, MD MSc

Blood (2015) 126 (23): 2258.

https://doi.org/10.1182/blood.V126.23.2258.2258

Published: 2015

Journal Articles

Validation Of Medical Inpatient Venous Thrombosis Risk Assessment (MITH) Score

Damon E Houghton, MD, Michael Desarno, MS, Peter Callas, Ph.D., Allen B Repp, MD, MS, Mary Cushman, MD, MSc, Samuel A Merrill, MD, PhD, John P. Winters, III, MD, Neil A Zakai, MD, MSc

Blood (2013) 122 (21): 2931.

https://doi.org/10.1182/blood.V122.21.2931.2931

Published: 2013

Journal Articles

Identifying Bleeding Risk In Medical Inpatients

John P. Winters, III, MD, Michael Desarno, MS, Damon Houghton, MD, Samuel A Merrill, MD, PhD, Peter Callas, Ph.D., Allen B Repp, MD, MS, Mary Cushman, MD, MSc, Neil A Zakai, MD, MSc

Blood (2013) 122 (21): 2933.

https://doi.org/10.1182/blood.V122.21.2933.2933

Published: 2013

Journal Articles

Clostridium Difficile As a Risk Factor For Hospital-Acquired Venous Thrombosis In Medical Inpatients

Samuel A Merrill, MD, PhD, Michael Desarno, MS, Damon Houghton, MD, John P. Winters, III, MD, Christopher Huston, MD, Peter Callas, Ph.D., Allen B Repp, MD, MS, Mary Cushman, MD, MSc, Neil A Zakai, MD, MSc

Blood (2013) 122 (21): 1682.

https://doi.org/10.1182/blood.V122.21.1682.1682

Published: 2013

NARROW

An Alternative Pathway Specific Flow Cytometric Assay to Detect Complement Activation in Atypical Hemolytic Uremic Syndrome (aHUS)

Chronic Kidney Disease, Hypertension and Cardiovascular Sequelae during Long Term Follow up of Adults with Atypical Hemolytic Uremic Syndrome

Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Center Study

Adult Hemophagocytic Lymphohistiocytosis-a Quality Improvement Initiative

Eculizumab cessation in atypical hemolytic uremic syndrome

Relative and Absolute Platelet Count Drops As a Risk Factor for Mortality, Bleeding, and Venous Thrombosis in Hospitalized Medical Patients

Validation Of Medical Inpatient Venous Thrombosis Risk Assessment (MITH) Score

Identifying Bleeding Risk In Medical Inpatients

Clostridium Difficile As a Risk Factor For Hospital-Acquired Venous Thrombosis In Medical Inpatients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only